The Effect of Ramatroban (BAY u 3405), a Thromboxane A2 Receptor Antagonist, on Nasal Cavity Volume and Minimum Cross-Sectional Area and Nasal Mucosal Hemodynamics after Nasal Mucosal Allergen Challenge in Patients with Perennial Allergic Rhinitis-Reference-Cited by-同舟云学术

The Effect of Ramatroban (BAY u 3405), a Thromboxane A2 Receptor Antagonist, on Nasal Cavity Volume and Minimum Cross-Sectional Area and Nasal Mucosal Hemodynamics after Nasal Mucosal Allergen Challenge in Patients with Perennial Allergic Rhinitis

Published:1998-12-31 Issue:6 Volume:118 Page:32-37
ISSN:0000-0000
Container-title:Acta Oto-Laryngologica
language:
Short-container-title:

Author:

Terada Nobuhisa,Yamakoshi Takayuki,Hasegawa Masaya,Tanikawa Hirokazu,Maesako Ken-Ichi,Ishikawa Kazuo,Konno Akiyoshi

Publisher

Informa UK Limited

Subject

Otorhinolaryngology,General Medicine

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Optimization of Indole Acetic Acid Derivatives as Potent and Selective CRTH2 Receptor Antagonists: Discovery of ACT‐774312;ChemMedChem;2023-04-14

2. 8‐ iso ‐prostaglandin E 2 induces nasal obstruction via thromboxane receptor in murine model of allergic rhinitis;The FASEB Journal;2021-09-24

3. The Biology of Prostaglandins and Their Role as a Target for Allergic Airway Disease Therapy;International Journal of Molecular Sciences;2020-03-08

4. Identification of new inhibitors for human hematopoietic prostaglandin D2 synthase among FDA-approved drugs and other compounds;Chemico-Biological Interactions;2015-03

5. Identification of 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonist;Journal of Medicinal Chemistry;2013-06-13